Cara-Lynne Schengrund
Photo
Academic title Professor of Biochemistry and Molecular Biology
College College of Medicine
Campuses Penn State Milton S. Hershey Medical Center
Department Biochemistry and Molecular Biology - HMC
Graduate programs Biochemistry and Molecular Biology
Cell and Molecular Biology
MD/PhD Degree Program
Integrative Biosciences
Neuroscience
Email Phone
  cxs8@psu.edu
  717 531 8048
 
Educational background
  Ph.D., Seton Hall University, 1966
Postdoctoral Training, Columbia University College of Physicians and Surgeons, 1967-1969
Research interests
 

Biological Role(s) of Gangliosides

Research interests in this laboratory focus on the biological roles of gangliosides, sialylated glycosphingolipids found in greatest concentration in the gray matter of the brain and, at the level of the cell, on the outer surface of the plasma membrane. While the exact cellular function(s) of these lipids is not known, they can enhance process formation by neuroblastoma cells maintained in vitro, and in vivo they can enhance recovery from certain lesions in the central nervous system. We are interested in how gangliosides given ip or iv cross the blood-brain barrier and in identifying which portion(s) of the lipid is needed to induce specific cellular responses. A second interest of this lab is to utilize the fact that gangliosides can function as ligands for the adherence of certain viruses, bacteria, and bacterial toxins as the starting point for the development of inhibitors of the adherence of such pathogens. Using cholera toxin as a model, we found that we could synthesize multivalent oligosaccharides that inhibited its adherence to cell surface associated GM1, a known ligand. Currently, this approach is being used in studies of botulinum neurotoxin A which adheres to the ganglioside GT1b.

Graphic
  Graphic
  Scanning electron photomicrographs of S20Y, cholinergic, murine neuroblastoma cells exposed to (A) medium alone, (B) medium containing 100 mg/ml of GM1, or (C) and (D) medium containing 70 mg/ml of the oligosaccharide portion of GM1. Note the increased length of the processes of cells exposed to GM1 or the oligosaccharide portion of GM1.
Areas of expertise
 
NeurotoxinsCholera Toxin
GangliosidesSynaptosomes
Receptors, Cell SurfaceVibrio cholerae
NeuroblastomaBlood-Brain Barrier
Muscle, SkeletalBrain
OligosaccharidesGalactosyltransferases
NeuritesTetanus Toxin
Escherichia coliSynapsins
GalactoseEnterotoxins
Bacterial ToxinsNerve Tissue Proteins
G(M1) GangliosideCarrier Proteins
Antibodies, MonoclonalMembrane Lipids
Botulinum Toxin Type ANeurons
GlycosphingolipidsMembrane Glycoproteins
Neuromuscular AgentsBacteria
VirusesCell Line
Anti-HIV AgentsGalactosides
HIV InfectionsHIV-1
PolyaminesGlycoconjugates
HIV Envelope Protein gp120Antiviral Agents
Macromolecular SubstancesDisease Transmission, Vertical
Milk, HumanSodium Dodecyl Sulfate
Central Nervous System Bacterial InfectionsCentral Nervous System Viral Diseases
Glycolipids
Publication author name
  Schengrund CL
Select publications
  Schengrund CL. Kovác P. A simple, nonenzymatic method for desialylating polysialylated ganglio-N-tetraose series gangliosides to produce GM1. 1999 Jan. J Lipid Res. 40(1):160-3.
National Institute of Neurological Disorders and Stroke
Thompson JP. Schengrund CL. Inhibition of the adherence of cholera toxin and the heat-labile enterotoxin of Escherichia coli to cell-surface GM1 by oligosaccharide-derivatized dendrimers. 1998 Sep 1. Biochem Pharmacol. 56(5):591-7.
National Institute of Neurological Disorders and Stroke
Fueshko SM. Schengrund CL. Murine neuroblastoma cells express ganglioside binding sites on their cell surface. 1990 May. J Neurochem. 54(5):1791-7.
National Institute of Allergy and Infectious Diseases
National Institute of Neurological Disorders and Stroke
Yowler BC. Stoehr SA. Schengrund CL. Oxidation and base-catalyzed elimination of the saccharide portion of GSLs having very different polarities. 2001 Apr. J Lipid Res. 42(4):659-62.
National Institute of Neurological Disorders and Stroke
Schengrund CL. Kovác P. UDP-6-deoxy-6-fluoro-alpha-D-galactose binds to two different galactosyltransferases, but neither can effectively catalyze transfer of the modified galactose to the appropriate acceptor. 1999 Jun 30. Carbohydr Res. 319(1-4):24-8.
National Institute of Neurological Disorders and Stroke

also ...
All publications